eimeria acervulina, strain 003 / eimeria brunetti, strain 034 / eimeria maxima, strain 013 / eimeria necatrix, strain 033 / eimeria tenella, strain 004
This is a summary of the European public assessment report (EPAR) for Evalon.It explains how the Agency assessed this veterinary medicine to recommend its authorisation in the European Union (EU) and its conditions of use. It is not intended to provide practical advice on how to use Evalon.
For practical information about using Evalon, animal owners or keepers should read the package leaflet or contact their veterinarian or pharmacist.
Evalon : EPAR - Summary for the public (PDF/78.52 KB)
First published: 13/05/2016
Last updated: 13/05/2016
|Agency product number||
vaccine against coccidiosis in chickens
|International non-proprietary name (INN) or common name||
|Anatomical therapeutic chemical veterinary (ATCvet) codes||
Laboratorios Hipra, S.A.
|Date of issue of marketing authorisation valid throughout the European Union||
Avda. La Selva 135
12/02/2021 Evalon - EMEA/V/C/004013 - R/0003
This medicine’s product information is available in all official EU languages.
Select ‘available languages’ to access the language you need.
Product information documents contain:
- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).
You can find product information documents for centrally authorised human medicines on this website. For centrally authorised veterinary medicines authorised or updated from February 2022, see the Veterinary Medicines Information website.
Live parasitic vaccines
Immunologicals for aves
For active immunisation of chicks from 1 day of age to reduce clinical signs (diarrhoea), intestinal lesions and oocysts output associated with coccidiosis caused by Eimeria acervulina, Eimeria brunetti, Eimeria maxima, Eimeria necatrix and Eimeria tenella.
Meeting highlights from the Committee for Medicinal Products for Veterinary Use (CVMP) 13-15 April 202116/04/2021
Meeting highlights from the Committee for Medicinal Products for Veterinary Use (CVMP) 8-10 December 202011/12/2020